.Nature Medication, Published online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- drug conjugate (ADC) tisotumab vedotin resulted in strengthened progression-free as well as general survival, resulting in FDA commendation and a new treatment option for people.